A Study of FL115 Injection in Combination With a PD-1 Antibody in Advanced Solid Tumors

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

September 8, 2025

Primary Completion Date

December 5, 2026

Study Completion Date

December 5, 2028

Conditions

Advanced Solid Tumors

Interventions

DRUG

FL115+PD-1

Combined treatment

All Listed Sponsors

lead

Suzhou Forlong Biotechnology Co.,Ltd,

INDUSTRY

NCT07131202 - A Study of FL115 Injection in Combination With a PD-1 Antibody in Advanced Solid Tumors | Biotech Hunter | Biotech Hunter